[go: up one dir, main page]

SE9003100D0 - Lipid formulation system - Google Patents

Lipid formulation system

Info

Publication number
SE9003100D0
SE9003100D0 SE9003100A SE9003100A SE9003100D0 SE 9003100 D0 SE9003100 D0 SE 9003100D0 SE 9003100 A SE9003100 A SE 9003100A SE 9003100 A SE9003100 A SE 9003100A SE 9003100 D0 SE9003100 D0 SE 9003100D0
Authority
SE
Sweden
Prior art keywords
lipid
matrix
particle forming
lipid particle
forming matrix
Prior art date
Application number
SE9003100A
Other languages
English (en)
Swedish (sv)
Inventor
M Nicklasson
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE9003100A priority Critical patent/SE9003100D0/xx
Publication of SE9003100D0 publication Critical patent/SE9003100D0/xx
Priority to IE324691A priority patent/IE62194B1/en
Priority to DE69119400T priority patent/DE69119400T2/de
Priority to PCT/SE1991/000639 priority patent/WO1992005771A1/fr
Priority to ES91919389T priority patent/ES2088024T3/es
Priority to EP91919389A priority patent/EP0514506B1/fr
Priority to CA002069760A priority patent/CA2069760C/fr
Priority to AU87105/91A priority patent/AU645143B2/en
Priority to JP3516564A priority patent/JP2855594B2/ja
Priority to DK91919389.6T priority patent/DK0514506T3/da
Priority to AT91919389T priority patent/ATE137667T1/de
Priority to PT99113A priority patent/PT99113B/pt
Priority to NO921231A priority patent/NO304729B1/no
Priority to FI922452A priority patent/FI107696B/fi
Priority to US08/242,054 priority patent/US5665379A/en
Priority to GR960402032T priority patent/GR3020674T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Fertilizers (AREA)
SE9003100A 1990-09-28 1990-09-28 Lipid formulation system SE9003100D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system
IE324691A IE62194B1 (en) 1990-09-28 1991-09-13 Lipid formulation systems
AT91919389T ATE137667T1 (de) 1990-09-28 1991-09-24 System auf basis einer lipidformulierung
CA002069760A CA2069760C (fr) 1990-09-28 1991-09-24 Systeme de formulation des lipides
DK91919389.6T DK0514506T3 (da) 1990-09-28 1991-09-24 Lipid-formuleringssystem
ES91919389T ES2088024T3 (es) 1990-09-28 1991-09-24 Sistema de formulacion de lipidos.
EP91919389A EP0514506B1 (fr) 1990-09-28 1991-09-24 Systeme de formulation de lipides
DE69119400T DE69119400T2 (de) 1990-09-28 1991-09-24 System auf basis einer lipidformulierung
AU87105/91A AU645143B2 (en) 1990-09-28 1991-09-24 Lipid formulation system
JP3516564A JP2855594B2 (ja) 1990-09-28 1991-09-24 脂質粒子形成マトリックス及びその製造方法
PCT/SE1991/000639 WO1992005771A1 (fr) 1990-09-28 1991-09-24 Systeme de formulation de lipides
PT99113A PT99113B (pt) 1990-09-28 1991-09-27 Processo para a preparacao de matrizes que originam particulas de lipidos
NO921231A NO304729B1 (no) 1990-09-28 1992-05-26 Lipidpartikkeldannende matriks
FI922452A FI107696B (fi) 1990-09-28 1992-05-27 Lipidipartikkelinmuodostusmatriisi ja menetelmä sen valmistamiseksi
US08/242,054 US5665379A (en) 1990-09-28 1994-05-13 Lipid particle forming matrix, preparation and use thereof
GR960402032T GR3020674T3 (en) 1990-09-28 1996-07-31 Lipid formulation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Publications (1)

Publication Number Publication Date
SE9003100D0 true SE9003100D0 (sv) 1990-09-28

Family

ID=20380490

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Country Status (15)

Country Link
EP (1) EP0514506B1 (fr)
JP (1) JP2855594B2 (fr)
AT (1) ATE137667T1 (fr)
AU (1) AU645143B2 (fr)
CA (1) CA2069760C (fr)
DE (1) DE69119400T2 (fr)
DK (1) DK0514506T3 (fr)
ES (1) ES2088024T3 (fr)
FI (1) FI107696B (fr)
GR (1) GR3020674T3 (fr)
IE (1) IE62194B1 (fr)
NO (1) NO304729B1 (fr)
PT (1) PT99113B (fr)
SE (1) SE9003100D0 (fr)
WO (1) WO1992005771A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
KR100220546B1 (ko) * 1994-02-04 1999-09-15 벵 헤르슬로프 호지성 담체 제제
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
EP1140021B1 (fr) 1998-12-23 2004-08-04 Idea Ag Formulation amelioree pour l'application topique non invasive in vivo
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
US7473432B2 (en) 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
EP1742663A2 (fr) 2004-04-15 2007-01-17 Chiasma, Ltd. Compositions capables de faciliter la penetration a travers une barriere biologique
CN101189029A (zh) * 2005-04-28 2008-05-28 盖伦尼卡技术股份公司 含脂相的药物剂型
SI1933809T1 (sl) * 2005-10-11 2012-08-31 Yissum Res Dev Co Sestavki za mazalno dajanje
RU2319506C2 (ru) * 2005-10-12 2008-03-20 Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" Способ получения носителя антигенов на основе липидов из морских макрофитов и тритерпенового гликозида кукумариозида
RU2322259C1 (ru) * 2006-06-29 2008-04-20 Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" Носитель антигенов
CA2963659C (fr) 2008-09-17 2020-06-23 Chiasma Inc. Utilisation de compositions orales d'octreotride
CN101926757B (zh) * 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
FI3253401T3 (fi) 2015-02-03 2025-07-09 Amryt Endo Inc Akromegallian hoitaminen suun kautta annettavalla oktreotidilla
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CA3217006A1 (fr) * 2021-05-03 2022-11-10 Thomas Gadek Lipides micronises

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
EP0158441B2 (fr) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Composition formatrice de liposomes
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
DE3852409T2 (de) * 1987-01-27 1995-04-20 Vestar Inc Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.

Also Published As

Publication number Publication date
IE62194B1 (en) 1994-12-28
IE913246A1 (en) 1992-04-08
FI922452L (fi) 1992-05-27
CA2069760A1 (fr) 1992-03-29
PT99113B (pt) 1999-02-26
DE69119400T2 (de) 1996-12-05
ES2088024T3 (es) 1996-08-01
EP0514506A1 (fr) 1992-11-25
CA2069760C (fr) 1998-02-10
NO304729B1 (no) 1999-02-08
JP2855594B2 (ja) 1999-02-10
ATE137667T1 (de) 1996-05-15
DE69119400D1 (de) 1996-06-13
FI922452A0 (fi) 1992-05-27
EP0514506B1 (fr) 1996-05-08
NO922084D0 (no) 1992-05-26
DK0514506T3 (da) 1996-08-12
WO1992005771A1 (fr) 1992-04-16
GR3020674T3 (en) 1996-10-31
FI107696B (fi) 2001-09-28
AU645143B2 (en) 1994-01-06
AU8710591A (en) 1992-04-28
PT99113A (pt) 1992-08-31
JPH05503711A (ja) 1993-06-17
NO922084L (no) 1992-05-26

Similar Documents

Publication Publication Date Title
DK0514506T3 (da) Lipid-formuleringssystem
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
ES2081349T3 (es) Rotogranulaciones y recubrimientos para enmascarar el sabor para la preparacion de comprimidos farmaceuticos de mascar.
FR2778406B1 (fr) Derives d'alpha-cetoamides, procede pour leur preparation, preparations pharmaceutiques les contenant, et leur utilisation en tant que medicaments anti-viraux
MC1119A1 (fr) Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
FR2679906B1 (fr) Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
ES2078190B1 (es) Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
KR900005990A (ko) 차전자(psyllium)-함유 생성물
HUT52953A (en) Process for producing pharmaceutical compositions against allergy, particularly nasal drops
ES2058988T3 (es) Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
Khan et al. Development of microencapsulation: A review of literature
NO933323D0 (no) Naerings- og medikamentblandinger paa basis av kitosan for administrering til droevtyggere
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
JPS5225015A (en) Process for preparing fine granular drugs
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
JPS61178914A (ja) ヒト及び動物の耳への局所投与用不溶性薬剤
FR2676648B1 (fr) Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral.
FR2732681B1 (fr) Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant
BE862053A (fr) Peptides contenant de la phenylglycine utiles comme medicaments, procede pour leur preparation et compositions pharmaceutiques en contenant
BE874154A (fr) Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
KR100486794B1 (ko) 다른 상 운반체 사이에서 하나 또는 그 이상의 활성인자를 이동시키는 방법